Invesco’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Invesco’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-52,100	Closed	-$2.81M	–	3823
2017 Q4	$2.81M	Sell	52,100 -63,965	-55%	-$3.5M	﹤0.01%	2351
2017 Q3	$6.63M	Sell	116,065 -7,573	-6%	-$444K	﹤0.01%	1793
2017 Q2	$7.44M	Buy	123,638 +9,117	+8%	+$519K	﹤0.01%	1723
2017 Q1	$6.24M	Buy	+114,521	New	+$5.64M	﹤0.01%	1841

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Invesco's BIVV Position: Q1 2018 in Review

Invesco sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 52,100 shares — an estimated $2.81M sold.

Invesco first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $7.44M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Invesco reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Invesco sold 52,100 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $2.81M.
Invesco first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Invesco's Bioverativ Inc. Common Stock position peaked at $7.44M in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Invesco's 13F filing for Q1 2018, filed 15 May 2018.